In Israel, Evogene Ltd. announced it had reached an important milestone in its crop disease collaboration with Monsanto Company with the demonstration of positive Fusarium resistance results with Evogene discovered genes. Additionally, Evogene announced the completion of the candidate gene discovery stage in the companies’ yield and abiotic stress collaboration, which mainly focuses on corn […]
In Missouri, Monsanto has reached a new global licensing agreement with the Broad Institute of MIT and Harvard for the use of the novel CRISPR-Cpf1 genome-editing technology in agriculture. The CRISPR-Cpf1 system represents an exciting advance in genome-editing technology, because it has potential to be a simpler and more precise tool for making targeted improvements […]
Late last week, the extended courtship between Bayer and Monsanto, which saw the dowry offer raised four times by Bayer, resulted in a $127.50 per share all-cash offer for Monsanto, which Monsanto’s board accepted. A whopping $66 billion in all — one of the largest all-cash acquisitions, ever. Reactions to the deal fall into three […]
In Israel, Evogene announced positive results from the testing of a set of the company’s discovered genes in corn and soybeans conducted this past season by its key collaborator, Monsanto. These are the first results for genes discovered and tested pursuant to a ‘Trait-First’ methodology implemented in the frame of the parties’ on-going, multi-year collaboration […]
In Switzerland, the Board of Syngenta confirmed that it has received an unsolicited proposal from Monsanto to acquire the company at a price of $45 billion (CHF449 per Syngenta share) with approximately 45 percent in cash. Reporting on the proposed acquisition has sugested that key Syngenta shareholders would back a deal which valued Syngenta at […]
In Israel, Evogen announced that its recently developed comprehensive gene optimization program is being incorporated into its multi-year collaboration with Monsanto Company. The addition of these new capabilities, which have been designed to optimize desired trait efficacy and potentially accelerate product development, follows the successful identification and validation by Evogene of more than one thousand […]
In Missouri, DuPont and Monsanto have announced that they have agreed on a settlement regarding their patent infringement lawsuits pending in the U.S. District Court in St. Louis, and that they will be dismissing the suits. Upon dismissal, the two companies will have no litigation against each other. The terms of the settlement are not […]
In Missouri, Monsanto Company announced fiscal year 2014 results slightly above the high end of its guidance range on the strength of its global seeds and traits business, the biggest driver of growth for the year. This is the company’s fourth consecutive year of strong ongoing earnings growth. Executives noted that the balance of the […]
In Denmark, Novozymes and Monsanto announced the completed closing of the The BioAg Alliance, as originally announced on December 10, 2013. Both companies will now focus on implementing the long-term strategic alliance. The BioAg Alliance is unique in the industry, bringing together Novozymes’ commercial BioAg operations and capabilities within microbial discovery, development and production with […]
In Missouri, Monsanto reported on track results for the first quarter of its fiscal year as the company reaffirmed its earnings growth and free cash flow guidance for fiscal year 2014. For Q1, Monsanto reported a net income of $368 million, compared to $339 million for the same quarter in 2013. Monsanto also confirmed its […]
